Missed OPT Congress This Year?

purchase-on-demand

Missed this year's virtual event? Access content across all of this year's programs On-Demand. At your convenience, access archived presentations for On-Demand learning from anywhere, at any time. 



VIRTUAL CONFERENCE PROGRAMS

Add Virtual Dates to Outlook




THANK YOU TO OUR SPONSORS


View All Sponsors




6th Annual OPT Congress VIRTUAL

March 30 - 31, 2021

Location: VIRTUAL, all times EDT

NEW for 2021: We are offering you the flexibility of either a 1 day or 2 day pass, allowing you to tailor this event to your specific needs.

OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. Join us in March when we bring together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers. Optimize your drug design, delivery and performance, accelerate time to market and achieve commercial success.

We are pleased to announce record attendance in 2020 - join this growing community and sign up today!


2021 Keynote Speakers Include:

Bob Brown, PhD

Melissa J. Moore, PhD
CSO, Moderna

Muthiah (Mano) Manoharan, PhD

Muthiah (Mano) Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals

Richard S. Geary, PhD

Richard S. Geary, PhD
Executive Vice President (EVP), Drug Development, Ionis Pharmaceuticals

Phil Baran, PhD

Phil Baran, PhD
Chair & Professor, Chemistry, Scripps Research Institute

Laura Sepp-Lorenzino, PhD

Laura
Sepp-Lorenzino, PhD

CSO, Intellia Therapeutics

Bob Brown, PhD

Bob Brown, PhD
CSO and Executive Vice President R&D, Dicerna Pharmaceuticals



With thanks to our Executive Advisory Board

Dmitry Samarsky, PhD
CTO, Sirnaomics

Muthiah (Mano) Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals

Arthur Levin, PhD
Executive Vice President, Research and Development, Avidity Biosciences

Lubo Nechev, PhD
Vice President Process and Analytical Sciences, Alnylam Pharmaceuticals

Ekkehard Leberer, PhD
Senior Life Sciences Consultant, ELBIOCON


65%
of Attendees
from Biotech
15%
of Attendees
from Pharma
130+
Unique
Organizations
10+
Hours of
Networking